Cooperative Agreement UG3CA297705
Award Date 9/8/25
Completion Date 8/31/27
Dollars Obligated $703K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
California, USA
Similar Awards
- The National Cancer Institute (NCI) awarded a $4,236,812 Project Grant under the Cancer Cause and Prevention Research federal grant program (CFDA 93.393) to Children's Hospital Los Angeles (CHLA). The grant, effective September 10, 2025 through August 31, 2029, will fund a study to evaluate the use of a patient navigation intervention to improve transition outcomes for young adult survivors of childhood cancer, particularly those from low socioeconomic status and underinsured/uninsured...
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) provides $192,489.00 to the University of Alabama at Birmingham to evaluate the implementation and impact of standard-of-care delivered oncology financial navigation. The oncology financial navigation intervention aims to help cancer patients prepare for out-of-pocket treatment costs, optimize health insurance, and access financial resources to combat cancer-related financial hardship....
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- This $5,041,790 cooperative agreement award from the National Cancer Institute (NCI), under the Cancer Centers Support Grants program (CFDA 93.397), will fund research projects at the University of California, San Francisco (UCSF) to improve cancer health disparities. The key products and services to be delivered include: Three translational cancer health disparities research projects focused on meningioma, prostate cancer, and breast cancer. The projects aim to evaluate the interplay of...
- This Cooperative Agreement award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $675,867 to the Medstar Health Research Institute Inc. to improve the delivery of practical geriatric assessment in community oncology settings. The goal is to increase the use of geriatric assessment, which can help mitigate adverse outcomes for older cancer patients, in clinics with limited specialized resources. The project will compare standard ASCO educational...
- This $658,743 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Kaiser Foundation Hospitals aims to develop and validate prediction models for trajectories of function, cognition, and quality of life among adults aged 65 and older with advanced non-small cell lung cancer during up to 6 months of chemotherapy and/or immunotherapy. The 5-year project builds on an ongoing observational cohort study of 130 older adults with advanced lung...
- The National Cancer Institute (NCI) awarded a $191,490 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) for the project "Implementing Pathways to Identify and Address Employment Concerns Among People with Cancer Across Diverse Clinical Settings." The overall objective is to identify and refer cancer patients with employment concerns to existing support resources through implementation and...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $185,693 to the Research Institute at Nationwide Children's Hospital to implement a digital health parent coaching intervention aimed at improving neurodevelopmental outcomes for young childhood cancer survivors in underserved communities. The project will be conducted over a 5-year period from March 1, 2025 to February 28, 2030. The Research Institute, a non-profit research...
- The National Cancer Institute awarded a $197,747 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of North Carolina at Chapel Hill. The grant, titled "IMPROVING AFFORDABILITY IN CANCER CARE THROUGH ECONOMIC SCREENING AND SUPPORT (I-ACCESS)", aims to pilot and refine a screening assessment and referral program to proactively identify cancer-related financial hardship in patients and connect them with financial education, counseling, and resources....
- The National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), awarded a $413,971 Project Grant to Duke University to develop and pilot test a novel nurse navigator-delivered intervention for women experiencing premature or early menopause after cancer treatment. The intervention will integrate personalized menopause education, decision support, skills to improve self-management, and cognitive behavioral techniques to manage menopausal...